Testis conservation studies in germ cell cancer justified by improved primary chemotherapy response and reduced delay, 1978-1994
Autor: | Douglas G. Altman, J.P. Blandy, R.T.D. Oliver, J. Ong |
---|---|
Rok vydání: | 1996 |
Předmět: |
Adult
Male Oncology medicine.medical_specialty Time Factors Urology medicine.medical_treatment Testicle Malignancy Cohort Studies Bleomycin Testicular Neoplasms Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans Sex organ Primary chemotherapy Neoplasm Metastasis Testicular cancer Aged Etoposide Retrospective Studies Chemotherapy business.industry Seminoma Middle Aged medicine.disease Surgery Treatment Outcome medicine.anatomical_structure Germ cell cancer Drug Resistance Neoplasm Germinoma Cisplatin business Orchiectomy |
Zdroj: | BJU International. 78:119-124 |
ISSN: | 1464-410X 1464-4096 |
DOI: | 10.1046/j.1464-410x.1996.04224.x |
Popis: | To investigate the need for the continued encouragement of early diagnosis of germ cell cancer of the testis, in view of the prevailing cure rate of 95%.The study comprised a retrospective review of 453 unselected and previously untreated patients referred to one centre between 1978 and 1984, comparing the delay from first symptoms with the histological diagnosis.With a delay of30 days, 20% of patients had overt metastases at presentation and if the delay was4 months. 55% had metastases (chi-squared trend = 15.9, P0.001); 18% of Stage-1 patients under surveillance with a delay of30 days relapsed, compared with 38% of those with a delay of4 months. During the period 1978-1983, 16% of patients were seen after a delay of60 days, during the period 1984-1988 the proportion was 22% and during 1989-1994, 31% (chi-squared trend = 8.2, P0.004). There was a non-significant trend for a more prolonged delay in those aged21 years and40 years. Thirty-two patients had chemotherapy with the primary tumour in situ; at orchidectomy, 13 of 18 had no viable malignancy and four of five with viable malignancy also had drug-resistant metastases. Fourteen did not undergo orchidectomy; within a median follow-up of 9 years, one developed a second (histologically different) tumour after 12 years. The outcome of preliminary attempts to use neoadjuvant chemotherapy with or without partial orchidectomy for patients with tumours in a solitary testis is discussed.These findings clearly justify the continued encouragement of early diagnosis, possibly best performed as part of an extended educational programme of genital health at puberty. The long-term potential for testis conservation should be explored initially in tumours in a solitary testis. |
Databáze: | OpenAIRE |
Externí odkaz: |